Journal of Cosmetic Dermatology, published by WILEY, stands as an influential platform in the field of dermatology, specifically focusing on cosmetic interventions and skin health. With its ISSN 1473-2130 and E-ISSN 1473-2165, this journal caters to a global audience, offering high-quality research and reviews that bridge the gap between scientific innovation and clinical practice. Ranked in the 74th percentile within the dermatology field, the journal occupies a notable position at Q2 in category rankings, reflecting its commitment to excellence and relevance in the cosmetic dermatology landscape. The journal encourages submissions that advance the knowledge of skin conditions, designs of cosmetic treatments, and patient care strategies, providing both researchers and practicing dermatologists with the insights needed to enhance clinical outcomes. Despite being a subscription-based platform, readers can engage deeply with a wealth of scholarly articles from 2002 through the present, which underscores its longstanding contribution to dermatological science.

CHROMATOGRAPHIA is a renowned scholarly journal published by Springer Heidelberg, specializing in the field of analytical chemistry, biochemistry, and organic chemistry since its inception in 1968. With its ISSN 0009-5893 and E-ISSN 1612-1112, the journal has maintained a robust profile, currently ranking in the Q3 and Q4 quartiles within significant Chemistry categories. Aimed at researchers, professionals, and students, CHROMATOGRAPHIA serves as a critical platform for disseminating innovative research, methodologies, and advancements related to chromatography and its applications in various scientific fields. While the journal is not open access, it offers significant visibility and scholarly contribution opportunities, making it an essential resource for those engaged in the vibrant intersection of chemistry and biochemistry.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.

JOURNAL OF FOOD SCIENCE, published by Wiley, is a premier journal dedicated to advancing the field of food science, bridging the gap between fundamental research and practical application. With an impressive impact factor reflecting its authoritative status, the journal is ranked in the Q1 quartile for Food Science in 2023 and boasts a Scopus ranking of #71 out of 389, placing it in the 81st percentile within Agricultural and Biological Sciences. First launched in 1936, the journal continues to serve as an essential platform for researchers, professionals, and students to disseminate innovative studies and reviews that address critical issues in food quality, safety, and technology. While not currently offering open access, its rigorous peer-review process ensures the dissemination of high-quality and impactful research. Researchers engaged in the vital disciplines of food science will find this journal indispensable for keeping abreast of cutting-edge developments in the field.

Journal of Dermatology & Dermatologic Surgery (JDDS) is a premier open access journal published by Wolters Kluwer Medknow Publications since 2018. This journal serves as a vital platform for the dissemination of cutting-edge research and advancements in the field of dermatology and dermatologic surgery. With its ISSN 2352-2410 and E-ISSN 2352-2429, JDDS strives to present high-quality articles that encompass clinical studies, innovative surgical techniques, and comprehensive reviews, thereby catering to the interests of researchers, medical professionals, and students alike. The journal has gained recognition within the academic community, evidenced by its Scopus ranks, placing it 237th out of 551 in the Medicine - Surgery category and 70th out of 142 in Medicine - Dermatology. The open access model not only enhances visibility but also encourages global collaboration and knowledge sharing in the rapidly evolving field of dermatology. Targeting the needs of diverse audiences, JDDS continues to foster an environment for scholarly communication and contributes significantly to the advancement of dermatologic sciences.

Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.

Aesthetic Plastic Surgery, published by Springer, is a premier journal dedicated to advancing the field of cosmetic and reconstructive surgery. Since its inception in 1976, the journal has established itself as a vital resource for surgeons, researchers, and medical professionals, achieving a remarkable H-Index and ranking in the top percentile for surgery disciplines within Scopus. With an impressive impact factor and categorized in the Q1 quartile for Surgery, this journal is committed to publishing high-quality articles that encompass a wide array of topics within aesthetic procedures, innovative techniques, and patient outcomes. Although it does not offer open access, the journal remains pivotal for those seeking to stay updated with the latest research, trends, and practice modalities in aesthetic surgical care. With a global reach, catering to scholars from the United States and beyond, Aesthetic Plastic Surgery is an invaluable asset for anyone immersed in the transformative realm of plastic surgery.

FOOD AND DRUG LAW JOURNAL is a vital publication dedicated to the intersection of law, public health, and pharmaceutical regulations. Established by the Food Drug Law Institute, this journal serves as an essential resource for legal practitioners, regulatory officials, and researchers focused on the complexities of food and drug legislation. While the journal has not yet achieved open access status, it remains a respected platform for scholarly discourse, reflected in its H-Index and quartile rankings, which place it in Q3 for Law and Q4 in several other relevant fields. Covering diverse topics related to the legal frameworks governing food and drug safety from 1992 to 2018 and continuing its impactful publication from 2021 to 2023, this journal provides critical insights into emerging legal challenges and compliance assurance in the domains of pharmacology and public health. As a publication with a distinct focus on these specialized areas, it aims to advance understanding and influence policy-making, making it a significant asset for professionals and academics alike.

Turk Dermatoloji Dergisi-Turkish Journal of Dermatology, published by Wolters Kluwer Medknow Publications, is a prominent platform dedicated to advancing the field of dermatology in Turkey and beyond. With an ISSN of 1307-7635 and an E-ISSN of 1308-5255, this journal plays a vital role in disseminating contemporary research and clinical advancements within the domain. While it is positioned in the Q4 quartile of dermatology journals, its contributions are essential for academics, medical practitioners, and students averse to the latest trends and breakthroughs in skin health. The journal assures accessibility to a broad audience, fostering knowledge exchange, collaboration, and innovation. Given its unique perspective rooted in Turkish dermatological practices, the Turkish Journal of Dermatology serves as a significant resource for enhancing professional competence and driving forward the science of dermatology through its vivid discussions and case studies. For researchers seeking a dedicated venue to publish their work or for professionals eager to stay informed, this journal is an indispensable resource in the ever-evolving landscape of dermatology.

The International Journal of Pharmaceutics, a prestigious publication from ELSEVIER, stands at the forefront of the pharmaceutical science field, exemplified by its impressive ranking of #15 out of 183 in Pharmacology, Toxicology, and Pharmaceutics, placing it in the 92nd percentile. Established in 1978, this journal has continuously provided a platform for researchers, professionals, and students to share groundbreaking discoveries and innovations in drug formulation, delivery systems, and pharmacokinetics. With a Q1 ranking in the 2023 category of Pharmaceutical Science, it underscores its significance in disseminating high-quality research that shapes clinical practices and enhances therapeutic outcomes. While the journal does not currently offer open access options, it remains accessible to subscribers through its publication based in Amsterdam, Netherlands, ensuring a broad reach within the scientific community. As it converges towards a vibrant future, the International Journal of Pharmaceutics continues to be an essential resource for anyone dedicated to advancing the field of pharmacy and drug development.